Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 13, 2006International Journal of CancerOpen Access

Circulating MMP2 and MMP9 in breast cancer—Potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories

View Full Paper
Ask AI
Bookmark
Share

Authors

SSStella SomiariWindber Research InstituteRSRichard I. SomiariLagos State Health Service CommissionCHCaroline HeckmanUniversity of Helsinki

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Somiari et al. (2006) studied this question.

synapsesocial.com/papers/6a91563ea97dfa43b7464040https://doi.org/10.1002/ijc.21989
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Serum matrix metalloproteinase‐9 in head and neck squamous cell carcinomais a prognostic marker2005 · 60 citations
  2. 2Metalloproteinases: role in breast carcinogenesis, invasion and metastasis2000 · 646 citations
  3. 3Limitations of the Gail Model in the Specialized Breast Cancer Risk Assessment Clinic2002 · 68 citations
  4. 4Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model2000 · 392 citations
  5. 5Nipple Aspirate Fluid Cytology and the Gail Model for Breast Cancer Risk Assessment in a Screening Population2005 · 65 citations